HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study

PURPOSE: Currently available local anesthetics have not demonstrated sufficient analgesia beyond 12–24 h postoperatively. The purpose of the study was to assess the safety and efficacy of HTX-011 (bupivacaine and meloxicam in Biochronomer(®) polymer technology), a long-acting investigational anesthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Viscusi, E., Minkowitz, H., Winkle, P., Ramamoorthy, S., Hu, J., Singla, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938470/
https://www.ncbi.nlm.nih.gov/pubmed/31429023
http://dx.doi.org/10.1007/s10029-019-02023-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938470/
https://www.ncbi.nlm.nih.gov/pubmed/31429023
http://dx.doi.org/10.1007/s10029-019-02023-6

Ejemplares similares